Biosimilars in the EU
Information guide for healthcare professionals Biosimilars in the EU Prepared jointly by the European Medicines Agency and the European Commission
Download Biosimilars in the EU
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
FRANÇAIS - cache.media.eduscol.education.fr
cache.media.eduscol.education.frOrganiser l’enseignement de l’oral FRANÇAIS Langage oral Informer et accompagner les professionnels de l’éducation CYCLES 2 3 4 eduscol.education.fr ...
Nomenclature Générale des Actes Professionnels (NGAP)
www.cnss.maArrêté du ministre de la santé n° 177-06 du 26 hija 1426 (27 janvier 2006) fixant la nomenclature générale des actes professionnels. Le ministre de la santé,
Les familles de risques professionnels
www.efficience-santeautravail.orgInformez-vous, visitez notre site et téléchargez nos fiches pratiques http://www.efficience-santeautravail.org Document conçu et réalisé par Efficience Santé au ...
INTERNATIONAL CODE OF ETHICS FOR OCCUPATIONAL …
www.icohweb.orgIV March 2, 2012 Foreword The International Code of Ethics for Occupational Health Professionals published by the International Commission on Occupational Health (ICOH) presents the ethical principles
Prévenir les risques professionnels dans les métiers de l ...
www.inrs.frQuiz / mode d’emploi 4-5 déplacements professionnels 6-8 optimisation du lieu de vie 9-11 aide à la prise des repas 12-13 aide à la toilette 15-17
La Nomenclature Générale des Actes Professionnels et la ...
www.smamform.frDRSM PACA-Corse - La Nomenclature générale des actes professionnels - Dr R.M - Nice 2007 Docteur R Moretti Avril 2006 CPA M 06 / DRSM PACA-Corse – Les affections de longues durées en odontologie- Dr R/M. - Nice 2007